SCHEMBL3264445

SCHEMBL3264445

C=CCOC(=O)c1cccc(CBr)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.50
ALDH1A1 P00352 2/20 0.44
TSHR P16473 2/20 0.44
HSD17B10 Q99714 1/20 0.44
MEP1B Q16820 1/20 0.44
CYP4F2 P78329 3/20 0.43
CYP4A11 Q02928 3/20 0.43
SNCA P37840 1/20 0.43
LOXL2 Q9Y4K0 1/20 0.42
RHOA P61586 1/20 0.42
ADRB2 P07550 1/20 0.41
ADRB1 P08588 1/20 0.41
ADRB3 P13945 1/20 0.41
SLC6A2 P23975 1/20 0.40
SLC6A3 Q01959 1/20 0.40
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
SLC7A5 Q01650 1/20 0.40
KDM4E B2RXH2 2/20 0.39
RAB9A P51151 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6676119 0.88 CYP4F2 (0.48) CYP3A4ALDH1A1TSHRHSD17B10MEP1B
SCHEMBL6660186 0.86 CYP3A4 (0.51) CYP3A4ALDH1A1TSHRHSD17B10MEP1B
SCHEMBL27362136 0.86 CYP3A4 (0.51) CYP3A4ALDH1A1TSHRHSD17B10MEP1B
SCHEMBL4564017 0.86 CYP3A4 (0.51) CYP3A4ALDH1A1TSHRHSD17B10CYP4F2
SCHEMBL16372021 0.85 CYP3A4 (0.61) CYP3A4ALDH1A1TSHRHSD17B10SNCA
SCHEMBL157805 0.85 CYP3A4 (0.61) CYP3A4ALDH1A1TSHRHSD17B10SNCA
SCHEMBL1800154 0.85 CYP3A4 (0.50) CYP3A4ALDH1A1TSHRHSD17B10CYP4F2
SCHEMBL30564418 0.85 CYP3A4 (0.50) CYP3A4ALDH1A1TSHRHSD17B10CYP4F2
SCHEMBL4980546 0.85 CYP3A4 (0.50) CYP3A4ALDH1A1TSHRHSD17B10MEP1B
Benzene SCHEMBL29140663 0.84 CYP3A4 (0.59) CYP3A4ALDH1A1TSHRHSD17B10SNCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008035379-A2 PROCESS FOR AND INTERMEDIATES OF LEUKOTRIENE ANTAGONISTS APTUIT LAURUS PRIVATE LIMITED (IN) 2008-03-27 WO claimed
EP-0360246-B1 3-Oxiranyl benzoic acids and derivatives thereof SEARLE & CO (US) 1994-03-30 EP claimed
EP-0360246-A1 3-Oxiranyl benzoic acids and derivatives thereof G.D. Searle & Co. (US) 1990-03-28 EP claimed
WO-2008035379-A3 PROCESS FOR AND INTERMEDIATES OF LEUKOTRIENE ANTAGONISTS APTUIT LAURUS PRIVATE LIMITED (IN) 2010-02-18 WO disclosed
WO-2008035379-A2 PROCESS FOR AND INTERMEDIATES OF LEUKOTRIENE ANTAGONISTS APTUIT LAURUS PRIVATE LIMITED (IN) 2008-03-27 WO disclosed
WO-2008035379-A2 PROCESS FOR AND INTERMEDIATES OF LEUKOTRIENE ANTAGONISTS APTUIT LAURUS PRIVATE LIMITED (IN) 2008-03-27 WO disclosed
US-5990326-A AN ANTIINFLAMMATORY AGENT AS INHIBITORS OF LEUKOTRIENE HYDROLASE G.D. SEARLE & CO. (US) 1999-11-23 US disclosed
EP-0360246-B1 3-Oxiranyl benzoic acids and derivatives thereof SEARLE & CO (US) 1994-03-30 EP disclosed
EP-0360246-A1 3-Oxiranyl benzoic acids and derivatives thereof G.D. Searle & Co. (US) 1990-03-28 EP disclosed